v3.25.2
Cash, Cash Equivalents, Marketable Securities, and Restricted Cash
6 Months Ended
Jun. 30, 2025
Cash, Cash Equivalents, and Short-Term Investments [Abstract]  
Cash, Cash Equivalents, Marketable Securities, and Restricted Cash Cash, Cash Equivalents, Marketable Securities, and Restricted Cash
As of June 30, 2025, the Company held $158.7 million in cash and cash equivalents and $72.3 million of marketable securities which are reported at fair value on the Company's Consolidated Balance Sheets. Unrealized holding gains and losses are generally reported within other comprehensive income (loss) in the Consolidated Statements of Comprehensive Income (Loss). If a decline in the fair value of a marketable security below the Company's cost basis is determined to be other-than-temporary or if an available-for-sale debt security’s fair value is determined to be less than the amortized cost and the Company intends or is more than likely to sell the security before recovery and it is not considered a credit loss, such security is written down to its estimated fair value as a new cost basis and the amount of the write-down is included in the Consolidated Statements of Operations as an impairment charge. If the unrealized loss of an available-for-sale debt security is determined to be a result of credit loss, the Company would recognize an allowance and the corresponding credit loss would be included in the Consolidated Statements of Operations.
The Company regularly invests excess operating cash in deposits with major financial institutions, money market funds, notes issued by the U.S. government, as well as fixed income investments and U.S. bond funds, both of which can be readily purchased and sold using established markets. The Company believes that the market risk arising from its holdings of these financial instruments is mitigated as, in accordance with Company policy, such securities are of high credit rating. Investments that have original maturities greater than three months but less than one year are classified as current. All marketable securities represent the investment of funds available for current operations, notwithstanding their contractual maturities.
Cash, cash equivalents and marketable securities are classified as current unless mentioned otherwise below and consisted of the following:
 As of June 30, 2025
(in thousands)CostGross
Unrealized
Gain
Gross
Unrealized
Loss
Fair
Value
Cash and cash equivalents$158,702 $— $— $158,702 
Commercial paper32,124 — (8)32,116 
U.S. government agency bonds27,580 62 (3)27,639 
Corporate debt securities12,370 19 (1)12,388 
Money market100 — — 100 
Certificates of deposit53 — — 53 
$230,929 $81 $(12)$230,998 
Included in cash and cash equivalents$158,702 $— $— $158,702 
Included in marketable securities72,227 81 (12)72,296 
Total cash, cash equivalents, and marketable securities$230,929 $81 $(12)$230,998 

 As of December 31, 2024
(in thousands)CostGross
Unrealized
Gain
Gross
Unrealized
Loss
Fair
Value
Cash and cash equivalents$213,752 $— $— $213,752 
Commercial paper18,082 (4)18,081 
U.S. government agency bonds16,524 (7)16,518 
Corporate debt securities1,446 — (2)1,444 
Money market100 — — 100 
Certificate of deposit51 — — 51 
$249,955 $$(13)$249,946 
Included in cash and cash equivalents$213,752 $— $— $213,752 
Included in marketable securities36,203 (13)36,194
Total cash, cash equivalents, and marketable securities$249,955 $$(13)$249,946 
For both the six months ended June 30, 2025 and June 30, 2024, there were no realized gains or losses.
Unrealized loss positions in the marketable securities as of June 30, 2025 reflect temporary impairments and are not a result of credit loss. Additionally, as these positions have been in a loss position for less than twelve months and the Company does not intend to sell these securities before recovery, the losses are recognized as a component of other comprehensive income (loss). The fair value of these marketable securities in unrealized loss positions are $37.1 million and $23.7 million as of June 30, 2025 and December 31, 2024, respectively.
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheets that sum to the total shown in the Consolidated Statements of Cash Flows.
As of June 30,
(in thousands)20252024
Cash and cash equivalents$158,702 $209,335 
Restricted cash3,313 3,022 
Cash, cash equivalents, and restricted cash shown in the Consolidated Statements of Cash Flows$162,015 $212,357